Table 5.
HLA and MICA immunization prevalence before (T0) and after (T1) H1N1 vaccination among renal transplanted patients and hemodialysis patients
| Proportion of Immunized Patients (%) | RT Patients (n = 111) |
HD Patients (n = 53) |
Controls (n = 21) |
P | |||
|---|---|---|---|---|---|---|---|
| T0 | T1 | T0 | T1 | T0 | T1 | ||
| anti-HLA Cl I | 15% | 14% | 25% | 25% | 19% | 19% | 1 |
| anti-HLA Cl II | 14% | 14% | 23% | 25% | 10% | 10% | 1 |
| anti-MICA | 14% | 11% | 15% | 19% | 5% | 10% | 0.39, 0.48, 1a |
HLA, human leukocyte antibody; Cl, class; MICA, MHC class I-related chain A antibody; RT, renal transplanted patients; HD, hemodialysis patients.
a
Before versus after vaccination, in renal transplant and hemodialysis patients and controls, respectively.